Sensorion: Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for Rare Disorders Europe conferences in October 2022
Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the f...
Read full article »
Sensorion is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of inner ear diseases.
Read more